Skip to content
healthcare.dev

ZEPBOUND

NDC 0002-2457, tirzepatide, injection, solution, from Eli Lilly and Company.

Product NDC
0002-2457
Status
Listed
Labeler
Eli Lilly and Company
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217806
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0002-2457 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIRZEPATIDE15 mg/.5mL

Pharmacologic classes

G-Protein-linked Receptor Interactions [MoA]; GLP-1 Receptor Agonist [EPC]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]; Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]

Package NDCNDC-11Package
0002-2457-80000022457804 SYRINGE in 1 CARTON (0002-2457-80) / .5 mL in 1 SYRINGE (0002-2457-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/487cd7e7-434c-4925-99fa-aa80b1cc776b
  • NADAC price for package 00002245780

    GET /v1/drugs/nadac/00002245780

Use it

Look up 0002-2457 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0002-2457 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0002-2457. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.